EMEA-001931-PIP01-16-M02

Key facts

Active substance
Human fibrinogen concentrate (BT524)
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0232/2020
PIP number
EMEA-001931-PIP01-16-M02
Pharmaceutical form(s)
Powder for solution for injection or infusion
Condition(s) / indication(s)
Treatment of congenital fibrinogen deficiency
Route(s) of administration
Intravenous use
Contact for public enquiries
Biotest AG

Tel. +49 6103801497
E-mail: Andrea.Wartenberg-Demand@biotest.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating